BamSEC and AlphaSense Join Forces
Learn More

Kezar Life Sciences Inc. – Material Contracts

NASDAQ: KZR    
Share price (3/26/26): $6.35    
Market cap (3/26/26): $46.5 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.14
from 10-K 15 pages Executive Employment Agreement
12/34/56
EX-10.13
from 10-K 15 pages Executive Employment Agreement
12/34/56
EX-10.11
from 10-K 2 pages Kezar Life Sciences, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 6 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Triple Asterisks [***] Denote Exclusions. Amendment No. 1 to Collaboration and License Agreement
12/34/56
EX-10.11
from 10-K 3 pages Kezar Life Sciences, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.4
from 10-Q 81 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Triple Asterisks [***] Denote Exclusions. Collaboration and License Agreement by and Between Kezar Life Sciences, Inc., Everest Medicines II (Hk) Limited, and Solely for Purposes of Section 2.8.4 (Everest’s Change of Control) and Section 15.6 (Guarantee), Everest Medicines Limited Dated as of September 20, 2023
12/34/56
EX-10.3
from 10-Q 8 pages October 6, 2023 Noreen Roth Henig, M.D. Address Re: Separation Agreement Dear Dr. Henig
12/34/56
EX-10.2
from 10-Q 9 pages October 2, 2023 John F. Fowler Address Re: Separation and Consulting Agreement Dear John: This Separation and Consulting Agreement (The “Agreement”) Summarizes the Terms of Your Separation From Kezar Life Sciences, Inc. (The “Company”) and Sets Forth the Severance Benefits Offered to You to Help in This Transition. 1. Employment Status and Final Payments
12/34/56
EX-10.1
from 10-Q 23 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Advisor Agreement
12/34/56
EX-10
from 10-K 9 pages First Amendment to Lease
12/34/56
EX-10.1
from 10-Q 22 pages Executive Employment Agreement
12/34/56
EX-10.2
from 10-Q 12 pages Kezar Life Sciences, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from 10-Q 22 pages Kezar Life Sciences, Inc. 2022 Inducement Plan Adopted by the Board of Directors: April 13, 2022 1. General
12/34/56
EX-10.9
from 10-K 3 pages Kezar Life Sciences, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.4
from 10-K 11 pages Kezar Life Sciences, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.9
from 10-K 2 pages Kezar Life Sciences, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 21 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 21 pages Executive Employment Agreement
12/34/56
EX-10.12
from 10-K 21 pages Amended and Restated Executive Employment Agreement
12/34/56